Health Canada drug identification number

DIN 02485605 — CYSTADROPS 0.37 %

CYSTADROPS is a solution of Cysteamine marketed by RECORDATI RARE DISEASES CANADA INC. The full Cysteamine monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.

DIN
02485605
Brand name
CYSTADROPS
Active ingredient
Cysteamine
Strength
0.37 %
Dosage form
SOLUTION
Route
OPHTHALMIC
Manufacturer
RECORDATI RARE DISEASES CANADA INC
Health Canada status
MARKETED
Drug class
Cystine-depleting agent (ophthalmic)

Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.

Other Cysteamine products

DINBrandStrengthFormManufacturerStatus
02464705 PROCYSBI 25 MG CAPSULE (DELAYED-RELEASE) AMGEN CANADA INC MARKETED
02464713 PROCYSBI 75 MG CAPSULE (DELAYED-RELEASE) AMGEN CANADA INC MARKETED

Rejoining the server...

Rejoin failed... trying again in seconds.

Failed to rejoin.
Please retry or reload the page.

The session has been paused by the server.

Failed to resume the session.
Please retry or reload the page.